Table 4.
The pooled prevalence of different genotypes of HPV among HIV-infected women in LMICs
| HPV genotypes | Random effects pooled %ES (95% CI) | No of studies | χ2 | DF | p value | I2 (%) |
|---|---|---|---|---|---|---|
| 16 | 20 (12.0–28-0) | 13 | 814.56 | 12 | < 0.001 | 98.53 |
| 18 | 15 (10.0–20.0) | 12 | 390.48 | 11 | < 0.001 | 97.18 |
| 26 | 4 (2.0–5.0) | 3 | 2.12 | 2 | 0.35 | 5.68 |
| 31 | 11 (7.0–14.0) | 11 | 260.91 | 10 | < 0.001 | 96.17 |
| 33 | 8 (5.0–11.0) | 8 | 72.55 | 7 | < 0.001 | 90.35 |
| 35 | 10 (6.0–14.0) | 9 | 120.78 | 8 | < 0.001 | 93.38 |
| 39 | 5 (3.0–8.0) | 7 | 53.68 | 6 | < 0.001 | 88.82 |
| 45 | 7 (5.0–10.0) | 10 | 114.13 | 9 | < 0.001 | 92.11 |
| 51 | 8 (5.0–10.0) | 9 | 37.74 | 8 | < 0.001 | 78.80 |
| 52 | 13 (9.0–18.0) | 9 | 157.30 | 8 | < 0.001 | 94.91 |
| 53 | 10 (5.0–16.0) | 7 | 83.80 | 6 | < 0.001 | 92.84 |
| 56 | 6 (4.0–9.0) | 7 | 45.42 | 6 | < 0.001 | 86.79 |
| 58 | 11 (8.0–14.0) | 11 | 94.54 | 10 | < 0.001 | 89.42 |
| 59 | 5 (3.0–7.0) | 7 | 66.49 | 6 | < 0.001 | 90.98 |
| 66 | 8 (3.0–12.0) | 5 | 44.36 | 4 | < 0.001 | 90.98 |
| 67 | 2 (1.0–3.0) | 2 | 1 | |||
| 68 | 6 (3.0–10.0) | 6 | 74.28 | 5 | < 0.001 | 93.27 |
| 69 | 4 (2.0–5.0) | 2 | 1 | |||
| 70 | 1 | |||||
| 73 | 5 (2.0–8.0) | 4 | 12.73 | 3 | 0.01 | 76.42 |
| 82 | 5 (3.0–6.0) | 4 | 3.54 | 3 | 0.32 | 15.21 |
HPV, human papillomavirus; χ2, heterogeinity chi-square; DF, degree of freedom; I2, heterogeneity; ES, effect size, CI, confidence interval